Search

everythinglearnresearchcommunity

for

Search:↓

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Some skin diseases may indicate a higher risk of metabolic syndrome and related health issues.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Changing how mesenchymal stromal cells are grown can improve their healing abilities.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Tight junctions are key for skin protection and controlling what gets absorbed or passes through the skin.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Children with atopic dermatitis often have sleep problems, affecting their growth and behavior.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Air pollution (PM10) increases skin inflammation and aging by reducing collagen and may trigger a repair response in skin cells.